NCT01122212

Completed

Introduction of Protein S100 in Diagnostics in Minor Brain I...

Kantonsspital Münsterlingen Source

Compare

Other study identifiers

Sponsor study identifier

S100-01 2010

Study Type

observational

Actual enrollment (reported)

128

Locations

1 country

Sites

1

Timeline

Study Start

January 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2010

Actual (reported)

Study Completion

January 2011

Actual (reported)

Brief Summary

In Patients with minor head injury measurement of protein S100 will be introduced to the emergency departement as another tool to rule out intracerebral bleeding.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 128 participants
Study completion date: January 2011
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2010
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
May 11, 2010
Actual (reported)
First Posted
May 13, 2010
Actual (reported)
Primary Completion
July 2010
Actual (reported)
Study Completion
January 2011
Actual (reported)

Last Updated: April 21, 2015
Status Verified: January 2012
Last Update Submitted: April 17, 2015

Conditions

Intracerebral Hemorrhage

Keywords

intracerebral hemorrhagect scansprotein s100inpatient treatment

Eligibility Criteria

Age4 Years+

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

All patients older than 3 years entering the ED of the Kantonsspital Münsterlingen with the history of a MHI during the last 6 hours and after getting informed consent

You may qualify if:

history of MHI during last 6 hours
older than 3 years

You may not qualify if:

more than 6 hours after MHI
younger than 4 years

Sponsors & Collaborators

Roche Diagnostic Ltd.
Industrycollaborator
Kantonsspital Münsterlingen
Otherlead

Study Sites (1)

Kantonsspital Münsterlingen

Münsterlingen, Thurgau, CH-8596, Switzerland

Biospecimen

Retention: SAMPLES WITH DNA

venous blood (Serum)

MeSH Terms

Conditions

Cerebral Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Martin Blay, MD
Kantonsspital Münsterlingen
PRINCIPAL INVESTIGATOR

Enrollment

128 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

May 11, 2010

First Posted

May 13, 2010

Study Start

January 2010

Date type not reported

This date has not been verified as actual or estimated.

NCT00827892

Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage

Phase 2Completed

NCT00810888

The Spot Sign for Predicting and Treating ICH Growth Study

Phase 2Completed

NCT00718328

Simvastatin For Intracerebral Hemorrhage Study

Phase 2Terminated

NCT01176214

WEANING-Study: "Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings

Phase 2Terminated

NCT04803292

Retrospective Cohort Study of Intracerebral Hemorrhage

Unknown

NCT02866838

Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist

Phase 2/3Completed

informed consent not given

Contact the study team to confirm eligibility.

Primary Completion

July 2010

Actual (reported)

Study Completion

January 2011

Actual (reported)

Last Updated

April 21, 2015

Record last verified: 2012-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01122212
Data provider: ClinicalTrials.gov
Source updated: 2015-04-21
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:33:43 UTC

Locations

CH(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations